Sunstone Life Science Ventures is an independent European venture capital investment firm based in Copenhagen, focused on life science therapeutics innovations. The firm typically makes its initial investments in companies raising Series A/B rounds across the European life science sector.
57% of their portfolio is in Biotech & Life Sciences. They made 2 investments in the last 12 months. Average disclosed round size is $33.6M (across 9 rounds with reported amounts).
Portfolio
24
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
42 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Kynexis | Series A | — | Aug 2026 |
 Step Pharma | Series C | — | Oct 2025 |
| RResalis | Series A | — | Jan 2024 |
 Resalis Therapeutics | Series A | — | Jan 2024 |
 Teitur Trophics | Series A | — | Mar 2023 |
 MinervaX | Unknown | — | Jan 2023 |
| MinervaX | Series B | — | Dec 2022 |
 TargED Biopharmaceuticals B.V. | Series A | — | Feb 2022 |
| TTarged Biopharmaceuticals | Series A | — | Jan 2022 |
| TargED Biopharmaceuticals B.V. | Series A | — | Jan 2022 |
 Io Biotech | Series B | — | Jan 2021 |
| SSynendos | Series A | — | Nov 2020 |
| SStipe Therapeutics | Series A | — | Oct 2019 |
| MinervaX | Series B | — | Jan 2019 |
 Galecto | Series C | — | Oct 2018 |
| PPrexton Therapeutics | Series B | — | Feb 2017 |
| PPrexton | Series B | $29M | Feb 2017 |
| PPrexton Therapeutics | Series B | $31M | Jan 2017 |
| PPrexton | Series B | $31M | Jan 2017 |
| PPrexton Therapeutics | Series A | $10M | Jan 2015 |
| PPrexton | Series A | $10M | Jan 2015 |
 Opsona | Series C | — | Oct 2013 |
| OOpsona Therapeutics | Series C | — | Oct 2013 |
| Opsona | Series C | — | Apr 2013 |
| OOpsona Therapeutics | Series C | — | Apr 2013 |
Page 1 of 2
Top Co-Investors
Ysios Capital9 shared
Sunstone Partners9 shared
Hadean Ventures7 shared
Novartis Venture Fund6 shared
Industrifonden5 shared
Innovestor5 shared
Wellington Management5 shared
M Ventures5 shared
Novo Capital5 shared
Forbion5 shared
Fountain Healthcare Partners5 shared
Roche Venture Fund5 shared
Amgen Ventures5 shared
Fund+4 shared
INKEF Capital4 shared
Kurma Partners4 shared
OrbiMed4 shared
Sunstone4 shared
Seroba Life Sciences4 shared
Omnes Capital4 shared
Last updated: 27 September 2026